Hospital Universitario De Fuenlabrada

At Hospital Universitario De Fuenlabrada, clinical trials in the Digestive System Diseases area focus strongly on Crohn’s disease, ulcerative colitis, and eosinophilic esophagitis. This research is aimed at testing new treatment options, improving long-term disease control, and evaluating how well therapies reduce symptoms and inflammation.

• Moderately to severely active Crohn’s disease and treatment response
• Ulcerative colitis control, remission, and maintenance of benefit
• Eosinophilic esophagitis and improvement of esophageal inflammation
• New approaches for patients who have not responded well to conventional care

The site’s gastroenterology team is contributing to studies that aim to make treatment more effective and more durable for people living with chronic intestinal disease.

A large share of the research portfolio is centered on Neoplasms, especially breast cancer in its early-stage, metastatic, HER2-positive, HER2-negative, and triple-negative forms. These trials are designed to compare cancer therapies, improve disease-free survival, and refine treatment strategies for patients at different stages of disease.

• Early breast cancer and prevention of recurrence
• Metastatic breast cancer and longer disease control
• HER2-positive, HER2-negative, and hormone receptor-positive disease
• Triple negative breast cancer and post-surgical treatment decisions

This oncology research includes testing newer targeted and combined treatment approaches to help identify options that may improve outcomes while maintaining tolerability.

The research program also includes trials in Digestive System Diseases and Neoplasms focused on colorectal cancer, including locally advanced disease, metastatic disease, and peritoneal metastases. The goal is to evaluate better treatment combinations and surgical strategies that may lower recurrence and extend survival.

• Locally advanced colon cancer and treatment intensification or de-escalation
• Metastatic colorectal cancer and sequencing of systemic therapies
• Peritoneal metastases and recurrence prevention after surgery
• Studies assessing whether adding targeted regional treatment improves outcomes

These studies reflect a strong interest in improving care for complex gastrointestinal cancers through both medical and surgical research.

Trials in Immune System Diseases and Immune System Phenomena at this site address conditions such as rheumatoid arthritis, hidradenitis suppurativa, and alopecia areata. The main purpose is to assess new therapies that may better control inflammation, reduce flare-ups, and improve quality of life.

• Rheumatoid arthritis and control of joint inflammation
• Hidradenitis suppurativa and reduction of skin lesions
• Alopecia areata and restoration of hair growth
• Evaluation of targeted anti-inflammatory treatments

This area highlights ongoing work to find more precise and better-tolerated options for chronic immune-related diseases.

The site is active in Skin and Connective Tissue Diseases and allergy-related research, including atopic dermatitis, allergic rhinitis, and pollen-related respiratory allergy. These studies are focused on improving symptom relief, reducing itching and irritation, and testing whether immunotherapy or biologic treatments can provide stronger control.

• Atopic dermatitis in children and adults
• Allergic rhinitis and rhinoconjunctivitis linked to grass and olive pollen
• Allergen immunotherapy to reduce sensitivity and symptoms
• Studies of treatments that aim to improve daily comfort and quality of life

This research combines allergy and dermatology expertise to support better management of common but persistent inflammatory conditions.

Trials in Hemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, and Cardiovascular Diseases include multiple myeloma, chemotherapy-related low platelet counts, and studies in obesity-related cardiovascular risk. The purpose of this work is to improve treatment delivery, support safer cancer care, and evaluate strategies that may reduce cardiovascular events.

• Newly diagnosed multiple myeloma and deeper treatment response
• Chemotherapy-induced thrombocytopenia and maintaining planned cancer treatment
• Cardiovascular disease and prevention of major adverse events
• Research aimed at supporting treatment safety across several specialties

At this Hospital/Clinic/Other health care facility, these studies show a broad interest in both disease control and the practical safety of ongoing therapy.

The portfolio also reaches into Respiratory Tract Diseases and Virus Diseases, with studies involving severe respiratory illness, acute respiratory distress syndrome, and advanced lung cancer. These trials are designed to test supportive care approaches, new cancer treatments, and therapies for infection-related complications.

• Acute respiratory distress syndrome linked to viral infections
• Advanced non-small cell lung cancer and treatment effectiveness
• Critical care research on sedation and ventilation support
• Evaluation of therapies intended to improve survival or recovery

This reflects a multidisciplinary research environment that extends beyond gastroenterology into broader hospital-based clinical investigation.